Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

rociletinib: Dosing and Uses

 

Classes: Antineoplastics, EGFR Inhibitor

Medically reviewed by Min Clinic Staff | Updated: January 2026

Dosing and uses of Rociletinib

 

Non-small Cell Lung Cancer (NSCLC)

Epidermal growth factor receptor (EGFR) inhibitor for treatment of patients with mutant EGFR NSCLC who have been previously treated with an EGFR-targeted therapy and have the EGFR T790M mutation

 

Pediatric dosage forms and strengths

Safety and efficacy not established

 

Pharmacology of Rociletinib

Mechanism of action

Targeted covalent (irreversible) epidermal growth factor receptor (EGFR) inhibitor